Iliac Stent-Grafts in TASC C-D Lesions
Endovascular Treatment of TASC II C-D Iliac Artery Lesions Using Covered Stents: A Retrospective Cohort Study
1 other identifier
observational
52
1 country
1
Brief Summary
This study aims to evaluate the midterm outcomes of patients with advanced aortoiliac artery narrowing (TASC C-D lesions) who were treated with covered iliac stent-grafts instead of open surgery. These patients were either too high-risk for surgery or refused it. Medical records from the past five years at a single cardiovascular surgery center in Turkey were reviewed retrospectively. The research focuses on the success rate of the procedure, complications, vessel patency, and the need for additional treatments. The results may help guide treatment decisions in similar high-risk patients who are not candidates for open vascular surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 14, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedJuly 20, 2025
June 1, 2025
1 year
June 14, 2025
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Technical and Clinical Success of Covered Iliac Stent-Graft
Based on review of patient records over the past 5 years, including procedural success and symptom relief
Within 5 years before the study start
Secondary Outcomes (1)
Complications, Patency Rates, and Reintervention Needs
Within 5 years before the study start
Eligibility Criteria
Patients diagnosed with peripheral artery disease and TASC C-D iliac lesions treated with covered stents between 2018 and 2023
You may qualify if:
- Patients with TASC C-D iliac artery lesions
- Procedures done within last 5 years in the same clinic
- Aged between 18-85 years
- Not eligible for open surgery or refused it
You may not qualify if:
- TASC A-B lesions
- Age \<18 or \>85
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsun University Faculty of Medicine
Samsun, 55090, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Emrah Ereren
Samsun University Faculty of medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2025
First Posted
July 3, 2025
Study Start
January 1, 2024
Primary Completion
January 1, 2025
Study Completion
August 30, 2025
Last Updated
July 20, 2025
Record last verified: 2025-06